Spark+ Research Flash Note

Spark+ Investor Relations Research has published a Research Flash Note on TruScreen Group Limited.

"TruScreen is entering a phase where several tangible commercial milestones have the potential to materially reshape investor perception. With early programs scaling, new distributors activating, and recurring SUS volumes rising, the next 6 to 12 months could potentially present a cluster of catalysts that could accelerate revenue traction..."


Any opinions, forecasts, recommendations or forward-looking statements in the report reflect the judgement and assumptions of Spark+. at the date of publication of the report. The Company does not endorse the findings or contents of the report, including any price target, earnings forecast or other statement about the Company’s prospects, and will not be responsible for any loss or damage arising in any way from errors, omissions or misstatements in the report or the use of, or reliance on, the report in any way.

Previous
Previous

Sichuan University clinical study confirms superiorityof TruScreen + hr-HPV co-testing

Next
Next

TruScreen validated as Superior Primary Screening Tool by World's largest Opto-Electronic Cervical Cancer Screening Study